REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/20/2026
Back to search
Official data from USPTO
PINPOINT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PINPOINT
ST13
US500000088768179Class
1, 5, 9, 40, 42
Filing
88768179
Registration
6325211
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/21/2026
Trademark type
Word
Nice classes
1, 5, 9, 40, 42
Filing date
01/21/2020
Registration date
04/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/20/2021
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
24
Owner location
CAMBRIDGE, GB
Examiner
MALYSZEK, KIMBERLY RAY
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
REVVITY DISCOVERY LIMITED
Horizon Discovery Limited
Representatives
Kevin A. Oliver Revvity, Inc.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparations in the nature of eukaryotic cellsisogenic cell lines and bio-production cell lines generated using base editing engineering for scientificlaboratory or medical research; reagentsplasmids and assays for scientificgenetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research toolsin the nature of chemicalbiological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNArRNAgRNAdeaminasenickaseribonucleotide protein (RNP) for use in scientificlaboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use
Class 5
Diagnostic preparations and materials generated by the use of base editing components for medical purposes; chemical preparation for use in DNA analysis for medical purposes; biological preparations in the nature of DNARNA and parts thereof for medical purposes; biological preparations in the nature of DNA extracts for medical purposes; biological preparations in the nature of gene editing enzymes for medical purposes; biological preparations in the nature of protein cell lysatesgenomic DNA preparations and Formalin FixedParaffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological preparations in the nature of biologicalbiochemical and chemical reagentsincluding living cellsgenetically modified cells and vectorsgenomic DNAcell cultures and mutant and normal isogenic cell line pairspeptidesproteins and nucleic acids or complexes of these molecules for medical use; all the aforesaid goods being medical preparations
Class 9
collections of DNA and gene sequences for research and reference purposes provided as DNA microarrays and DNA chips
Class 40
Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnosticmedical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services
Class 42
Custom cell-line engineering services; gene base-editing services for research purposes; gene engineering services; research and development services in the creation of databases or collections of information on biologicals including cells and cell lines for research purposes; creating and providing databases or collections of information on normal and mutated genes for research purposes; providing DNA reference standards for research purposes; providing DNA reference databases being collections of DNA and gene sequences for research purposes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes for research or analysis purposes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling for research purposes; design of clinical trials for research purposes; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapiesgenome editinggenetic engineering and gene therapies
Publications
History of USPTO decisions and trademark events.
35 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/12/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
07/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/02/2021
PUBO
PUBLISHED FOR OPPOSITION
02/02/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/13/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/28/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/26/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/26/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/26/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/29/2020
GNRT
NON-FINAL ACTION E-MAILED
09/29/2020
CNRT
NON-FINAL ACTION WRITTEN
09/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/26/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/26/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/09/2020
GNRT
NON-FINAL ACTION E-MAILED
04/09/2020
CNRT
NON-FINAL ACTION WRITTEN
04/09/2020
DOCK
ASSIGNED TO EXAMINER
04/08/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/30/2020
ALIE
ASSIGNED TO LIE
03/26/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/25/2020
NWAP
NEW APPLICATION ENTERED
01/24/2020
Continuous trademark protection
Get notified about every new filing that threatens PINPOINT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.